MEROPEN Side Effects

6870816-0 | Pneumonitis
on Jul 12, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with pneumonitis, atrial fibrillation (What is atrial fibrillation?), hypertension, insomnia, pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis. Meropen dosage: Single Use.. During the same period patient was treated with FIRSTCIN (View Firstcin Review and Firstcin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ARTIST (View Artist Review and Artist Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPENON (View Aspenon Review and Aspenon Label ), DEPAS (View Depas Review and Depas Label ), MYSLEE (View Myslee Review and Myslee Label ), MEDICON (View Medicon Review and Medicon Label ).

6847829-8 | Hepatic Function Abnormal
Patient was taking Meropen (View Usage). Patient had the following side effects: hepatic function abnormal on Jun 02, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with pyrexia and. Meropen dosage: . During the same period patient was treated with SULPERAZON (View Sulperazon Review and Sulperazon Label ). Patient was hospitalized.

6774949-9 | Hepatic Function Abnormal
Adverse event was reported on Jun 08, 2010 by a Female patient taking Meropen (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 89 years of age, After Meropen was administered, patient had the following side effects: hepatic function abnormal. Patient was hospitalized.

6771948-8 | Bone Marrow Failure, Small Intestinal Haemorrhage
on Jun 11, 2010 Male patient from JAPAN , 37 years of age, weighting 166.7 lb, was diagnosed with enteritis infectious, psoriasis and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, small intestinal haemorrhage. Meropen dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CLINDAMYCIN PHOSPHATE (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).


6768255-6 | Hepatic Function Abnormal
on Jun 02, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with pyrexia and was treated with Meropen (View Usage). Patient had the following side effects: hepatic function abnormal. Meropen dosage: . During the same period patient was treated with SULPERAZON (View Sulperazon Review and Sulperazon Label ). Patient was hospitalized.

6767229-9 | Pneumonitis
Patient was taking Meropen (View Usage). After Meropen was administered, patient had the following side effects: pneumonitis on Jun 02, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with pneumonitis and. Meropen dosage: Single Use.

6760386-X | Bone Marrow Failure, Small Intestinal Haemorrhage
Adverse event was reported on May 27, 2010 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with enteritis infectious, psoriasis and. Location: JAPAN , 37 years of age, weighting 166.7 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, small intestinal haemorrhage. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CLINDAMYCIN PHOSPHATE (View Clindamycin Phosphate Review and Clindamycin Phosphate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6749997-5 | Interstitial Lung Disease
on May 21, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). Patient had the following side effects: interstitial lung disease. Meropen dosage: . Patient was hospitalized.

6749504-7 | Infectious Mononucleosis
on May 25, 2010 Female patient from JAPAN , weighting 97.00 lb, was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: infectious mononucleosis (What is infectious mononucleosis?). Meropen dosage: . During the same period patient was treated with MILNACIPRAN HYDROCHLORIDE (View Milnacipran Hydrochloride Review and Milnacipran Hydrochloride Label ).

6749199-2 | Depressed Level Of Consciousness, Headache, Red Blood Cell Count Decreased, Restlessness
Patient was taking Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, headache (What is headache?), red blood cell count decreased, restlessness on May 20, 2010 from JAPAN Additional patient health information: Female patient , 40 years of age, was diagnosed with pleurisy, hyperphosphataemia, renal failure chronic, shunt thrombosis, reflux oesophagitis and. Meropen dosage: 0.5 G Daily, Three Times Per Week. During the same period patient was treated with PRECIPITATED CALCIUM CARBONATE (View Precipitated Calcium Carbonate Review and Precipitated Calcium Carbonate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GASTER D (View Gaster D Review and Gaster D Label ), PANALDINE (View Panaldine Review and Panaldine Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ). Patient was hospitalized.

6743893-5 | Hepatic Function Abnormal
Adverse event was reported on May 17, 2010 by a Female patient taking Meropen (View Usage) (Dosage: ) . Location: JAPAN , 89 years of age, Patient had the following side effects: hepatic function abnormal. Patient was hospitalized.

6736965-2 | Renal Disorder
on May 17, 2010 Male patient from JAPAN , 81 years of age, was diagnosed with infection (What is infection?) and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: renal disorder. Meropen dosage: . During the same period patient was treated with FIRSTCIN (View Firstcin Review and Firstcin Label ).

6733647-8 | Hepatic Function Abnormal
on May 11, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with pyrexia and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Meropen dosage: . Patient was hospitalized.

6730317-7 | Hepatic Function Abnormal
Patient was taking Meropen (View Usage). Patient had the following side effects: hepatic function abnormal on May 29, 2009 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Meropen dosage: . During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ).

6700381-X | Renal Disorder
Adverse event was reported on Apr 23, 2010 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: JAPAN , 81 years of age, After Meropen was administered, patient had the following side effects: renal disorder.

6686200-9 | Depressed Level Of Consciousness, Disorientation, Dyskinesia, Hypotension, Overdose, Tremor, Vomiting, White Blood Cell Count Decreased
on Apr 08, 2010 Female patient from JAPAN , 64 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, disorientation, dyskinesia, hypotension, overdose, tremor, vomiting, white blood cell count decreased. Meropen dosage: . Patient was hospitalized.

6676320-7 | Hepatic Function Abnormal
on Apr 01, 2010 Female patient from JAPAN , 89 years of age, was treated with Meropen (View Usage). Patient had the following side effects: hepatic function abnormal. Meropen dosage: . Patient was hospitalized.

6673105-2 | Haemorrhagic Diathesis
Patient was taking Meropen (View Usage). After Meropen was administered, patient had the following side effects: haemorrhagic diathesis on Mar 30, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with pneumonia (What is pneumonia?), arteriosclerosis obliterans and. Meropen dosage: . During the same period patient was treated with ZOSYN (View Zosyn Review and Zosyn Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), BULTAL (View Bultal Review and Bultal Label ), INSULIN (View Insulin Review and Insulin Label ).

6668804-2 | Anuria, Renal Failure Acute
Adverse event was reported on Apr 01, 2010 by a Male patient taking Meropen (View Usage) (Dosage: ) . Location: JAPAN , 76 years of age, Patient experienced the following unwanted or unexpected effects: anuria, renal failure acute. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), UNASYN (View Unasyn Review and Unasyn Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ).

6666868-3 | Epilepsy
on Mar 24, 2010 Male patient from JAPAN , 90 years of age, was diagnosed with pneumonia aspiration and was treated with Meropen (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?). Meropen dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6573516-X | Pneumonia
on Jan 29, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: pneumonia (What is pneumonia?). Meropen dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6573515-8 | Hepatic Function Abnormal, Platelet Count Decreased, Renal Impairment
Patient was taking Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, platelet count decreased, renal impairment on Feb 03, 2010 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Meropen dosage: .

6571774-9 | Hepatic Function Abnormal
Adverse event was reported on Jan 26, 2010 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with pancreatitis acute and. Location: JAPAN , 60 years of age, Patient had the following side effects: hepatic function abnormal. During the same period patient was treated with TANNALBIN (View Tannalbin Review and Tannalbin Label ), COLIOPAN (View Coliopan Review and Coliopan Label ). Patient was hospitalized.

6552430-X | Hyperbilirubinaemia
on Jan 15, 2010 Male patient from JAPAN , 86 years of age, was diagnosed with escherichia bacteraemia, pneumonia primary atypical and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: hyperbilirubinaemia. Meropen dosage: . During the same period patient was treated with CIPROXAN (View Ciproxan Review and Ciproxan Label ), CAPISTEN (View Capisten Review and Capisten Label ), REMINARON (View Reminaron Review and Reminaron Label ), NEUART (View Neuart Review and Neuart Label ), MIRACLID (View Miraclid Review and Miraclid Label ). Patient was hospitalized.

6552366-4 | Depressed Level Of Consciousness
on Jan 15, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness. Meropen dosage: . During the same period patient was treated with MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

6544806-1 | Depressed Level Of Consciousness
Patient was taking Meropen (View Usage). Patient had the following side effects: depressed level of consciousness on Jan 12, 2010 from JAPAN Additional patient health information: Male patient , 92 years of age, was diagnosed with urosepsis, asthma (What is asthma?), hypertension, hyperuricaemia, angina pectoris, hypothyroidism and. Meropen dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), MEDICON (View Medicon Review and Medicon Label ), COLDRIN (View Coldrin Review and Coldrin Label ), DIOVAN (View Diovan Review and Diovan Label ), SALOBEL (View Salobel Review and Salobel Label ), NITOROL R (View Nitorol R Review and Nitorol R Label ), SIGMART (View Sigmart Review and Sigmart Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ).

6541910-9 | Interstitial Lung Disease
Adverse event was reported on Jan 08, 2010 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: JAPAN , 77 years of age, After Meropen was administered, patient had the following side effects: interstitial lung disease. Patient was hospitalized.

6541837-2 | Pneumonitis
on Jan 08, 2010 Female patient from JAPAN , 82 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis. Meropen dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6523870-X | Stupor
on Dec 24, 2009 Male patient from JAPAN , 74 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). Patient had the following side effects: stupor. Meropen dosage: .

6523830-9 | Interstitial Lung Disease
Patient was taking Meropen (View Usage). After Meropen was administered, patient had the following side effects: interstitial lung disease on Dec 24, 2009 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with meningitis (What is meningitis?) and. Meropen dosage: . Patient was hospitalized.

6523446-4 | Pyrexia
Adverse event was reported on Dec 22, 2009 by a Female patient taking Meropen (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: JAPAN , 72 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CRAVIT (View Cravit Review and Cravit Label ). Patient was hospitalized.

6523421-X | Depressed Level Of Consciousness
on Dec 24, 2009 Male patient from JAPAN , 92 years of age, was diagnosed with urosepsis, asthma (What is asthma?), hypertension, hyperuricaemia, angina pectoris, hypothyroidism and was treated with Meropen (View Usage). Patient had the following side effects: depressed level of consciousness. Meropen dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), MEDICON (View Medicon Review and Medicon Label ), COLDRIN (View Coldrin Review and Coldrin Label ), DIOVAN (View Diovan Review and Diovan Label ), SALOBEL (View Salobel Review and Salobel Label ), NITOROL R (View Nitorol R Review and Nitorol R Label ), SIGMART (View Sigmart Review and Sigmart Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ).

6516100-6 | Hyperbilirubinaemia
on Dec 14, 2009 Male patient from JAPAN , 86 years of age, was diagnosed with escherichia bacteraemia, pneumonia primary atypical and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: hyperbilirubinaemia. Meropen dosage: . During the same period patient was treated with CIPROXAN (View Ciproxan Review and Ciproxan Label ). Patient was hospitalized.

6507813-0 | Hepatic Function Abnormal
Patient was taking Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Dec 10, 2009 from JAPAN Additional patient health information: Male patient , 39 years of age, was diagnosed with pneumonia (What is pneumonia?), sedation, fluid replacement, convulsion prophylaxis, diabetes insipidus (What is diabetes insipidus?), brain oedema, gastric ulcer, wound infection and. Meropen dosage: . During the same period patient was treated with DORMICUM (View Dormicum Review and Dormicum Label ), LACTEC (View Lactec Review and Lactec Label ), MUSCURATE (View Muscurate Review and Muscurate Label ), PITRESSIN (View Pitressin Review and Pitressin Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), GLYCEOL (View Glyceol Review and Glyceol Label ), ZANTAC (View Zantac Review and Zantac Label ), SEFMAZON (View Sefmazon Review and Sefmazon Label ). Patient was hospitalized.

6507740-9 | Oculomucocutaneous Syndrome
Adverse event was reported on Dec 10, 2009 by a Male patient taking Meropen (View Usage) (Dosage: ) . Location: JAPAN , 51 years of age, Patient had the following side effects: oculomucocutaneous syndrome.

6505017-9 | Agranulocytosis, Deafness
on Dec 11, 2009 Female patient from JAPAN , 34 years of age, was diagnosed with meningitis bacterial and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: agranulocytosis, deafness. Meropen dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6492530-6 | Depressed Level Of Consciousness
on Dec 01, 2009 Male patient from JAPAN , 92 years of age, was diagnosed with urosepsis and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness. Meropen dosage: . During the same period patient was treated with ADONA (View Adona Review and Adona Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), DIOVAN (View Diovan Review and Diovan Label ), SALOBEL (View Salobel Review and Salobel Label ), NITOROL R (View Nitorol R Review and Nitorol R Label ), SIGMART (View Sigmart Review and Sigmart Label ), THYRADIN (View Thyradin Review and Thyradin Label ), LASIX (View Lasix Review and Lasix Label ).

6492291-0 | Multi-organ Failure, Renal Failure
Patient was taking Meropen (View Usage). Patient had the following side effects: multi-organ failure, renal failure on Dec 08, 2009 from JAPAN Additional patient health information: Male patient , weighting 1.54 lb, was diagnosed with pyrexia, peritonitis and. Meropen dosage: . During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), FUNGUARD (View Funguard Review and Funguard Label ).

6490299-2 | Hepatic Function Abnormal
Adverse event was reported on Dec 02, 2009 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), antiviral prophylaxis, hypertension, dyslipidaemia, pyrexia and. Location: JAPAN , 73 years of age, After Meropen was administered, patient had the following side effects: hepatic function abnormal. During the same period patient was treated with PACETCOOL (View Pacetcool Review and Pacetcool Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ), AMLODIN (View Amlodin Review and Amlodin Label ), CRESTOR (View Crestor Review and Crestor Label ), ARTIST (View Artist Review and Artist Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALONAL (View Calonal Review and Calonal Label ). Patient was hospitalized.

6490210-4 | Pancytopenia
on Dec 01, 2009 Male patient from JAPAN , 14 years of age, was diagnosed with serratia infection and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Meropen dosage: . Patient was hospitalized.

6490195-0 | Pyrexia
on Dec 04, 2009 Female patient from JAPAN , 72 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Meropen (View Usage). Patient had the following side effects: pyrexia. Meropen dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CRAVIT (View Cravit Review and Cravit Label ). Patient was hospitalized.

6479682-9 | Hepatic Function Abnormal
Patient was taking Meropen (View Usage). After Meropen was administered, patient had the following side effects: hepatic function abnormal on Nov 26, 2009 from JAPAN Additional patient health information: Male patient , 39 years of age, was diagnosed with pneumonia (What is pneumonia?), sedation, fluid replacement, convulsion prophylaxis, diabetes insipidus (What is diabetes insipidus?), brain oedema, gastric ulcer, wound infection and. Meropen dosage: . During the same period patient was treated with DORMICUM (View Dormicum Review and Dormicum Label ), LACTEC (View Lactec Review and Lactec Label ), MUSCURATE (View Muscurate Review and Muscurate Label ), PITRESSIN (View Pitressin Review and Pitressin Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), GLYCEOL (View Glyceol Review and Glyceol Label ), ZANTAC (View Zantac Review and Zantac Label ), SEFMAZON (View Sefmazon Review and Sefmazon Label ). Patient was hospitalized.

6473987-3 | Agranulocytosis, Deafness
Adverse event was reported on Nov 25, 2009 by a Female patient taking Meropen (View Usage) (Dosage: ) was diagnosed with meningitis bacterial and. Location: JAPAN , 34 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, deafness. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6468504-8 | Depressed Level Of Consciousness
on Nov 26, 2009 Male patient from JAPAN , 92 years of age, was diagnosed with urosepsis and was treated with Meropen (View Usage). Patient had the following side effects: depressed level of consciousness. Meropen dosage: . During the same period patient was treated with ADONA (View Adona Review and Adona Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), DIOVAN (View Diovan Review and Diovan Label ), SALOBEL (View Salobel Review and Salobel Label ), NITOROL R (View Nitorol R Review and Nitorol R Label ), SIGMART (View Sigmart Review and Sigmart Label ), THYRADIN (View Thyradin Review and Thyradin Label ), LASIX (View Lasix Review and Lasix Label ).

6462102-8 | Hepatic Function Abnormal
on Nov 19, 2009 Male patient from JAPAN , 73 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: hepatic function abnormal. Meropen dosage: .

6461913-2 | Urticaria
Patient was taking Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Nov 17, 2009 from JAPAN Additional patient health information: Female patient , 47 years of age, was diagnosed with febrile neutropenia and. Meropen dosage: .

6461590-0 | Hyperbilirubinaemia
Adverse event was reported on Nov 18, 2009 by a Male patient taking Meropen (View Usage) (Dosage: ) was diagnosed with escherichia bacteraemia, pneumonia primary atypical and. Location: JAPAN , 86 years of age, Patient had the following side effects: hyperbilirubinaemia. During the same period patient was treated with CIPROXAN (View Ciproxan Review and Ciproxan Label ). Patient was hospitalized.

6460574-6 | Multi-organ Failure, Renal Failure
on Nov 25, 2009 Male patient from JAPAN , child 0 years of age, weighting 16.53 lb, was diagnosed with pyrexia, peritonitis and was treated with Meropen (View Usage). After Meropen was administered, patient had the following side effects: multi-organ failure, renal failure. Meropen dosage: . During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), FUNGUARD (View Funguard Review and Funguard Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ).

6456842-4 | Agranulocytosis, Deafness
on Nov 16, 2009 Female patient from JAPAN , 34 years of age, was diagnosed with meningitis bacterial and was treated with Meropen (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, deafness. Meropen dosage: . During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6441809-2 | Interstitial Lung Disease
Patient was taking Meropen (View Usage). Patient had the following side effects: interstitial lung disease on Nov 06, 2009 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with pneumonia (What is pneumonia?), convulsion, acute respiratory distress syndrome and. Meropen dosage: . During the same period patient was treated with ALEVIATIN (View Aleviatin Review and Aleviatin Label ), HORIZON (View Horizon Review and Horizon Label ), PHENOBARBITAL SODIUM 100MG CAP (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), UNASYN (View Unasyn Review and Unasyn Label ), ELASPOL (View Elaspol Review and Elaspol Label ). Patient was hospitalized.